Related Experiment Video
Updated: Apr 19, 2026

Measurement of T Cell Alloreactivity Using Imaging Flow Cytometry
Published on: April 19, 2017
Biomarkers of calcineurin inhibitor nephrotoxicity in transplantation
Mangalee Fernando1, Philip W Peake, Zoltan H Endre
1Department of Nephrology, Prince of Wales Hospital, Barker St., Randwick, Sydney, NSW, Australia.
Abstract:
Over 35 years of use has demonstrated the revolutionary therapeutic benefits of calcineurin inhibitors (CNI) in not only preventing transplant rejection, but also the renal and nonrenal toxicity of CNI. Acute reversible and insidious irreversible forms of CNI nephrotoxicity have been identified, with ischemia from an imbalance between vasoconstrictors and vasodilators playing an important role. The ongoing search to define toxicity pathways has been enriched by 'Omics' studies. Changes in proteins including those involved in activation of pro-inflammatory responses, oxidative stress, ER stress and the unfolded protein response have been identified, and these may serve as biomarkers of toxicity. However, the current standard of CNI toxicity, histology, lacks specificity, which creates challenges for biomarker validation. This review focuses on progress in nephrotoxic pathway identification of CNI and biomarker validation.
Insights
Calcineurin inhibitors (CNI) prevent transplant rejection but cause kidney toxicity.
Area of Science:
- Nephrology
- Immunosuppression
- Translational Medicine
Background:
- Calcineurin inhibitors (CNI) are vital immunosuppressants post-transplant.
- CNI use is associated with significant renal and non-renal toxicities.
- Understanding CNI nephrotoxicity mechanisms is crucial for patient outcomes.
Purpose of the Study:
- To review advancements in identifying calcineurin inhibitor nephrotoxicity pathways.
- To discuss the progress in validating biomarkers for CNI toxicity.
- To highlight the role of 'Omics' studies in this research.
Main Methods:
- Literature review focusing on CNI nephrotoxicity.
- Analysis of 'Omics' data to identify molecular pathways.
- Evaluation of current diagnostic standards (histology) and biomarker potential.
Main Results:
- Ischemia, driven by vasoconstrictor-vasodilator imbalance, is a key factor in CNI nephrotoxicity.
- 'Omics' studies reveal protein changes linked to inflammation, oxidative stress, and ER stress.
- Current histological assessments for CNI toxicity lack specificity, hindering biomarker validation.
Conclusions:
- Progress has been made in defining CNI nephrotoxicity pathways using molecular approaches.
- Biomarker validation remains challenging due to limitations in current diagnostic methods.
- Further research is needed to develop specific and reliable biomarkers for CNI nephrotoxicity.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Kidney Transplant III: Nursing Management
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Serum Studies: Renal Function Tests
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

